Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity.
Entasobulin is a indolizine-glyoxylamide based small molecule that demonstrate substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.
















